--- title: CDMOs offering Cell-Line Development with Gene Therapy path: /explore/cell-line-development/gene-therapy companies_count: 31 --- # CDMOs offering Cell-Line Development with Gene Therapy 31 published CDMOs match Cell-Line Development and Gene Therapy. Locations in this set include United States, United Kingdom, China, Japan, Denmark, and Germany. Capabilities that show up most often in this set: CMC Analytical Development, Process Development, CMC Regulatory Submission Support, Quality Control Testing, and Viral Vector Manufacturing. ## Matching companies - [4basebio](/companies/4basebio) - 4basebio manufactures high-quality synthetic DNA and RNA using proprietary cell-free amplification technology, supporting mRNA vaccines, viral vectors, gene editing, and cell/gene therapies from research through GMP-grade clinical production. - [AGC Biologics](/companies/agcbio) - Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities. - [Advaxia](/companies/advaxia) - cGMP CDMO specializing in adenovirus vaccine development and manufacturing with a 100% batch approval rate and 10+ years of biologics expertise, serving major pharmaceutical and biotech clients. - [Aldevron](/companies/aldevron) - Aldevron is a CDMO specializing in mRNA manufacturing with LNP encapsulation and fill/finish, viral vector production, plasmid DNA, and gene therapy solutions from discovery through commercialization. - [Andelyn Biosciences](/companies/andelynbio) - CDMO specializing in plasmid DNA and AAV viral vector manufacturing for cell and gene therapy, with digital-first platform emphasizing data integrity and collaboration. - [Asimov](/companies/asimov) - Asimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies. - [BioInnovatise](/companies/bioinnovatise) - BioInnovatise provides fast, reliable CDMO services for plasmid DNA, viral vector packaging, and CRISPR-Cas9 research with turnaround times of 7–28 days. - [BioVectra](/companies/biovectra) - North American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada. - [Biomay AG](/companies/biomay) - GMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities. - [Boston Institute of Biotechnology, LLC](/companies/bostonbib) - Full-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L. - [CDMO Network](/companies/cdmonetwork) - CDMO Network is a biomanufacturing partner-routing platform that connects biotech sponsors with specialized CDMO partners across modalities, development stages, and geographies to reduce integration friction and accelerate program execution. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [Cell and Gene Therapy Catapult](/companies/ct) - UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle. - [Charles River Laboratories](/companies/criver) - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years. - [Creative Biogene](/companies/creative-biogene) - Creative Biogene provides viral vector manufacturing, cell line development, and RNA therapeutic platforms including AAV, lentivirus, adenovirus production, circular RNA synthesis, and lipid nanoparticle formulation for gene therapy and vaccine applications. - [CuriRx, Inc.](/companies/curirx) - CuriRx, Inc. is a Wilmington, Massachusetts contract research and development organization. It offers formulation development, prefilled syringe and lyophilization services, bioprocessing, and analytical testing to pharmaceutical companies of all sizes. - [ElevateBio](/companies/elevate) - Advanced therapies CDMO providing discovery, process development, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA, and gene editing programs from preclinical through commercial scale. - [FUJIFILM Biotechnologies](/companies/fujifilm-biotechnologies) - CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities. - [Genezen](/companies/genezen) - Viral vector CDMO specializing in AAV, lentiviral, and retroviral manufacturing for gene and cell therapies, with cGMP facilities in Indiana and Massachusetts supporting preclinical through commercial-scale production. - [Lonza Cell & Gene Technologies](/companies/lonza) - Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.